AXT, Inc. (AXTI) | The Buildout — AI Infrastructure

Mkt cap · 52-wk · YTD · delayed
Updated Aug 12, 2026Q2 FY2026 reviewed
AXT produces indium phosphide and other compound semiconductor substrates that feed AI data center optical interconnect.
InP revenue $30.7M
Q2 2026 indium phosphide revenue, highest in company history.
Q2 revenue $47.6M
Up nearly 77% QoQ and 164% YoY; highest quarterly revenue.
Gross margin 45.0%
Non-GAAP Q2 2026, up from 8.2% a year earlier.
Export permits gate
Timing unpredictable; many international shipments need China permits.
The Buildout Takeaway
AXT has shifted from a substrate recovery story to a funded capacity race for InP. The question is whether export permits and execution can keep pace with the demand the company describes.
11 analysts·7 Buy4 Hold0 Sell
Coverage is thin — only 3 price estimates, so no target is shown

No annual full-year guidance on record. Q3 2026: revenue floor ~$66M · non-GAAP EPS $0.30–$0.32 · non-GAAP OpEx ~$10.5M.
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

AXT makes indium phosphide, gallium arsenide, and germanium substrates. Its InP wafers feed the lasers and photodetectors used in optical transceivers that connect GPUs inside AI data centers. The company is vertically integrated: it designs its own crystal-growth furnaces and owns raw-material subsidiaries. Manufacturing is concentrated in China, and export permits gate many shipments outside China.

Market Cap
Revenue (TTM)$126M
Revenue Growth+45.8%
EBITDA Margin (TTM)8.7%
Net Cash$332M
Earnings Beats3 of 7
P/E (TTM)
EV/EBITDA (TTM)

What We Like

  • InP revenue reached $30.7M in Q2 2026, about 64.5% of total revenue, up from $13.6M in Q1.
  • Non-GAAP gross margin reached 45.0% in Q2 2026, up from 8.2% a year earlier.
  • InP backlog is 'well over $100 million' and management says it is still growing.
  • Cash and investments rose to $749 million after the $632.5 million April raise.
  • Management targets InP run-rates of about $60M per quarter exiting 2026 and $130M per quarter exiting 2027.

What We’re Watching

  • Q3 actual results against the $66M revenue floor will show whether permit flow is improving.
  • Inventory reached $96.3M in Q2; management calls it deliberate staging, but conversion remains unproven.
  • The LTSA counterparty names remain partially garbled in the transcript ('Casella' or 'Kasela'); contract size and timing remain unresolved.
  • Capacity execution: end-2026 and end-2027 run-rates, plus 6-inch qualification, are moving targets.
Bottom Line

The thesis is strengthening: record revenue, a return to profitability, signed prepaid supply agreements, and a funded expansion plan all point the same direction. The key open question is whether export permits and execution can convert the deliberate inventory build and capacity ramp into revenue without a mismatch.

Next upQ3 2026 results, measured against management's approximately $66 million revenue floor, test whether permit flow and InP conversion extend the step-up. After that, the end-2026 InP run-rate target of about $60 million per quarter tests the capacity ramp.
Last Quarter — Q2 FY2026

Earnings

AXT reported Q2 2026 revenue of $47.6 million, up nearly 77% QoQ and 164% YoY. Non-GAAP gross margin was 45.0%, compared with 8.2% a year earlier. Q2 2026 indium phosphide revenue nearly doubled the prior InP record of about $17 million.

MetricQ2 FY2026Q1 FY2026Q2 FY2025YoY
Revenue$48M$27M$18M+164.4%
Gross margin44.9%29.6%8.0%+3690bps
EBITDA$10M$1M−$4M−331.1%
EPS$0.19$-0.03$-0.16−216.3%
Indium Phosphide revenue$30.7M$13.6Mn/a
Revenue for the second quarter of 2026 is $47.6 million. This is the highest quarterly revenue in AXT history. Up nearly 77% from $26.9 million in the first quarter. And up a 164% from $18 million the second quarter of 2025.— Gary L. Fischer, Chief Financial Officer, July 30, 2026

Management tone: Management described Q2 as an inflection point and the beginning of a multiyear growth phase, while remaining specific that export-permit timing is unpredictable. The CFO disclosed a gross-margin internal target beginning with a 5 and asked an analyst not to publicize it.

Management Guidance

Q3 2026 guidance is a revenue floor of approximately $66 million, non-GAAP net income per share of $0.30–$0.32, GAAP net income per share of $0.29–$0.31, non-GAAP OpEx of approximately $10.5 million, GAAP OpEx of approximately $11 million, and an estimated share count of approximately 66.5 million shares. The floor covers revenue realizable with permits already in hand or not required; additional permits could provide significant upside.

Business Trajectory

Trajectory

Revenue is accelerating: Q2 2026 revenue of $47.6 million grew 77% QoQ, versus 17% QoQ in Q1. The driver is indium phosphide, up to $30.7 million from $13.6 million, on data center demand and additional export approvals. Non-GAAP gross margin widened to 45.0% from 29.9% in Q1 as volume absorbed fixed costs and mix shifted toward larger diameters. Inventory rose deliberately to $96.3 million ahead of permit-driven shipments.

Revenue & Margin Trajectory
RevenueGross margin$0$20$40$22M$20M$21M$24M$28M$26M$24M$27M$29M$22M$20M$25M$20M$18M$21M$22M$26M$27M$31M$34M$35M$38M$40M$40M$35M$27M$19M$19M$17M$20M$23M$28M$24M$25M$19M$18M$28M$23M$27M$48M35%45%crosses into profitQ3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
RevenueGross margin$0$20$40$22M$20M$21M$24M$28M$26M$24M$27M$29M$22M$20M$25M$20M$18M$21M$22M$26M$27M$31M$34M$35M$38M$40M$40M$35M$27M$19M$19M$17M$20M$23M$28M$24M$25M$19M$18M$28M$23M$27M$48M35%45%crosses into profitQ3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
Gross margin as reported.
Share Price — 12 Months
$50$100$052-wk high $133Aug '25NovFeb '26MayAug '26
52-week range $2–$133.
Share Price — 12 Months
$50$100$052-wk high $133Aug '25NovFeb '26MayAug '26
52-week range $2–$133.
The Numbers

The Model

The model projects FY+1 revenue of $150 million and EBITDA of $19 million, a 12.7% margin. FY+2 revenue is projected at $245 million with EBITDA of $58 million, a 23.6% margin. The near-term anchor is the InP capacity ramp and the Q3 revenue floor; FY+2 is driven by the planned exit run-rate expansion and long-term supply-agreement conversion.

Revenue & EBITDA Projections
REVENUE$88M$150M$245MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN−$13M$19M$58M23.6%FY25FY+1 (E)FY+2 (E)
REVENUE$88M$150M$245MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN−$13M$19M$58M23.6%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$88M$150M$245M
YoY Growth+69.7%+63.3%
EBITDA−$13M$19M$58M
EBITDA Margin-14.6%12.7%23.6%

Projections are the median of 5 independent model runs. The model’s revenue sits 10.2% above analyst consensus.

Q3 2026 guidance is a revenue floor of approximately $66 million, non-GAAP net income per share of $0.30–$0.32, GAAP net income per share of $0.29–$0.31, non-GAAP OpEx of approximately $10.5 million, GAAP OpEx of approximately $11 million, and an estimated share count of approximately 66.5 million shares. The floor covers revenue realizable with permits already in hand or not required; additional permits could provide significant upside.

What Could Go Right — and Wrong

What good looks like
  • Export permits, including possible U.S. permits, become more regular and unlock international revenue.
  • InP capacity reaches management's targets of about $60 million per quarter exiting 2026 and about $130 million per quarter exiting 2027.
  • Coherent, Casella/Kasela, and Lumentum LTSAs convert prepayments to revenue through Q4 and into 2027.
  • 6-inch InP substrates in development for next-generation optical roadmaps.
  • Non-GAAP gross margin sustains near 45% or expands toward management's internal target starting with a 5.
What could go wrong
  • Export permit flow stalls, leaving inventory stranded and pushing revenue into later periods.
  • AI data center optical spending pauses or the 100G/1.6T transceiver upgrade cycle corrects.
  • Customer and competitor InP capacity additions reduce merchant demand or pricing power.
  • The 2027 facility build or 6-inch qualification slips, delaying the capacity ramp.
  • Historical ASP declines of about 5% to 10% per year reassert once supply catches demand.
What’s Next

Looking Ahead

The next 12 months are framed by management's Q3 revenue floor of about $66 million, followed by an end-2026 InP run-rate target of about $60 million per quarter. LTSA revenue conversion is expected to build through Q4 and into 2027, and 6-inch InP substrates are in development for next-generation optical roadmaps. The 2027 facility is intended to roughly double capacity again to about $130 million per quarter exiting 2027.

Catalysts
  • Q3 2026Q3 revenue and profitability — Tests the $66M floor and whether additional export permits create upside.
  • Q4 2026LTSA revenue conversion ramps — Tests whether Coherent and Casella/Kasela prepayments begin converting to revenue.
  • Exiting 2026End-2026 InP run-rate — Tests management's target of about $60M per quarter InP capacity.
  • 2027Casella/Kasela contract starts — Tests the 2027 start of the agreement with the undisclosed counterparty.
  • Exiting 20272027 InP facility run-rate — Tests the target of about $130M per quarter exiting 2027.
  • Late 2027+Co-packaged optics inflection — Tests whether CPO demand begins to add a second InP demand wave.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$99M$88M$126M-11.0%
Gross Margin24.0%11.2%32.2%1,278bps
EBITDA−$6M−$13M$76M-122.4%
EBITDA Margin-5.8%-14.6%8.7%875bps
Net Income−$12M−$21M$4M-82.8%
Free Cash Flow−$18M−$19M−$192M
Net Cash

Key Ratios (Trailing)

Valuation
  • P/E TTM
  • EV/EBITDA TTM
  • EV/Revenue TTM
  • Price/FCF TTM
Profitability
  • Gross Margin (TTM)32.2%
  • EBITDA Margin (TTM)8.7%
  • Net Margin (TTM)3.3%
  • ROIC0.6%
  • FCF Conversion-211.9%
  • SBC / Revenue1.8%
Reference

The Company

AXT, Inc. develops and produces high-performance compound and single-element semiconductor substrates — indium phosphide, gallium arsenide, and germanium — plus raw materials through consolidated subsidiaries. Indium phosphide is the core AI-infrastructure product: AXT InP wafers feed laser diodes and photodetectors used in optical transceivers that connect GPUs in AI data centers. The 10-Q attributed Q1 substrate growth to higher InP wafer demand from data center applications and passive optical networks after additional China export approvals.

AXT operates one segment and is vertically integrated. It designs and builds its own crystal-growth furnaces and controls some raw-material inputs through JinMei/Jingmei high-purity indium refining and BoYu pBN crucibles. Its manufacturing footprint is almost entirely in China: six sites in Beijing, DingXing, Kazuo, and Tianjin, with Q1 2026 long-lived assets of $165.5M in China out of $166.5M total. It depends on single or limited suppliers for quartz tubing, arsenic, phosphorus, and polishing solutions.

Business Segments

Indium Phosphide
~64.5% of Q2 2026 revenue ($30.7M)
Substrates for lasers and photodetectors in optical transceivers; primarily data center applications.
Growth driver: 100G/1.6T transceiver migration and AI datacenter optical buildout.
Gallium Arsenide
~13.9% of Q2 2026 revenue ($6.6M)
Semi-insulating GaAs for RF, power amplifiers, and datacenter VCSELs.
Growth driver: Datacenter VCSEL adoption and wireless end markets.
Raw materials and other
~21.0% of Q2 2026 revenue ($10.0M)
High-purity indium, pBN crucibles, and other consolidated raw-material sales.
Growth driver: Internal InP capacity expansion pulling raw-material volume.

Competitive Landscape

The 10-K lists primary competitors as Sumitomo Electric Industries, Japan Energy (JX), Freiberger Compound Materials, Umicore, China Crystal Technology Corp. (CCTC), and Vital Materials. Management says the competitive landscape for high-quality InP is limited to a few players because of high technical barriers, and believes AXT is in the strongest position to add capacity quickly. The 10-K also cautions that competitors have adopted similar crystal-growth technology, eroding AXT's differentiation, and that certain products have seen annual ASP declines of about 5–10%.

  • Sumitomo Electric Industries
    Listed in 10-K as primary competitor; no further discussion supplied.
  • Japan Energy (JX)
    Listed in 10-K as primary competitor; no further discussion supplied.
  • Freiberger Compound Materials
    Listed in 10-K as primary competitor; no further discussion supplied.
  • Umicore
    Listed in 10-K as primary competitor; no further discussion supplied.
  • China Crystal Technology Corp. (CCTC)
    Listed in 10-K as primary competitor; no further discussion supplied.
10-K also names Vital Materials as a primary competitor; individual competitive dynamics for each named firm are not further described in the source material.

Supply Chain

AXT sits upstream in the AI optical chain, supplying InP, GaAs, and Ge substrates while vertically integrated into high-purity indium and pBN crucibles. It also relies on single or limited external suppliers for quartz tubing, arsenic, phosphorus, and polishing solutions.

Supplier
JinMei / Jingmei
Consolidated subsidiary; high-purity indium refining.
Supplier
BoYu
Consolidated subsidiary; pBN crucibles used in crystal growth.
Supplier
Single or limited external suppliers
Quartz tubing, arsenic, phosphorus, and polishing solutions.
Vertically integrated; own furnaces and raw materials.
AXTI
Develops and produces InP, GaAs, and Ge substrates with internal raw-material supply.
$25.4M prepayment
Q2 2026 LTSA; prepayment converts to revenue as product ships.
Casella/Kasela
$22.3M prepayment
Q2 2026 LTSA; contract starts in 2027.
not disclosed
Agreement announced week of Q2 call; prepayments exist.
Top five customers
~30% of Q2 revenue
No single customer over 10% of revenue.

Analysis updated Aug 12, 2026, reviewing Q2 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on AXTI: Earnings recap